Digital Diabetes Management Market Analysis And Forecast To 2031: By Product (Smart Glucose Meter, Continuous Blood Glucose Monitoring System, Smart Insulin Pens, Smart Insulin Pumps, Apps), By Type (Wearable Devices, Handheld Devices), By End-use (Hospit

Digital Diabetes Management Market Analysis And Forecast To 2031: By Product (Smart Glucose Meter, Continuous Blood Glucose Monitoring System, Smart Insulin Pens, Smart Insulin Pumps, Apps), By Type (Wearable Devices, Handheld Devices), By End-use (Hospital, Home settings, Diagnostic Centers), And Region

The global digital diabetes management market was valued at USD 14.8 Billion in 2021 and it is anticipated to grow up to USD 71.9 Billion by 2031, at a CAGR of 17.1% during the forecast period.

Digital diabetes management (DDM) is the use of digital technologies to help people with diabetes manage their disease. This can include apps, websites, wearable devices, and other tools that help people track their blood sugar levels, monitor their diet and activity, and receive guidance and support from healthcare providers. Digital diabetes management can help people with diabetes better manage their disease and improve their health. For example, tracking blood sugar levels can help people identify patterns and make necessary adjustments to their diet or medication. Monitoring activity can help people ensure they are getting enough exercise. And receiving guidance and support from healthcare providers can help people stay on track with their treatment plans.

Market Trends and Drivers

The growing number of diabetic patients around the world will benefit from the use of digital diabetes management products and services. According to the International Diabetes Federation (IDF), almost 463 million people worldwide had diabetes in 2019. The need for continuous blood glucose monitoring among thes Along with rising disease burden, rising diagnostic and treatment cost will have a favourable impact on market statistics. The growing knowledge of diabetes management and home care will add to the high cost of diagnosis, encouraging total market growth. Diabetes patients rely heavily on continuous monitoring tools and must seek treatment in the event of fluctuations in order to avoid serious complications. Thus, technology advancements in disease management enable diabetes management through the use of digital devices, allowing for the tracking, monitoring, and sharing of lifestyle data with concerned healthcare professionals. As a result, rising adoption of novel technologies for chronic disease management will drive the digital diabetes management market growth.

Market Restraints and Challenges

There are a few key restraints and challenges in the Digital Diabetes Management market. Firstly, the lack of awareness about digital diabetes management solutions and their benefits among patients and healthcare professionals is a major challenge. Secondly, the high cost of these solutions is another key restraint. Lastly, the lack of standardization in digital diabetes management is also a key challenge.

Global Digital Diabetes Management Market Segmental Overview

The report analyses the global digital diabetes management market based on product, type, end-user, and region.

Global Digital Diabetes Management Market by Product

Based on product, the market is segregated as smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, and apps. The smart insulin pens segment is expected to expand at the fastest rate during the forecast period. The segment's rapid growth is primarily due to the development of artificial intelligence and the rising number of product launches. The market is dominated by a number of players who are concentrating on developing smart insulin pens, boosting their presence, and improving their product offerings. For instance, Novo Nordisk introduced intelligent insulin pens in the UK in March 2022. The first-ever monitoring and recording technology is now available to diabetic patients getting care through the NHS.

Global Digital Diabetes Management Market by Type

Based on the type, the digital diabetes management market is divided into the wearable devices, and handheld devices. Wearable Devices was valued significant market size in 2021 and is anticipated to grow at highest CAGR from 2022-2030. The market's expansion is mostly due to technical improvements such as the introduction of artificial intelligence, the introduction of new products such as closed-loop pump systems and smart insulin patches, and the increasing use of self-insulin delivery devices in diabetes treatment.

Global Digital Diabetes Management Market by End-user

With regards to end-user, the digital diabetes management market is divided into hospitals, home settings, and diagnostic centers. Home settings generated considerable revenue in 2021 and is expected to grow at a highest CAGR over the analysis period. The growing awareness of diabetes treatment, user-friendly interfaces of modern digital devices, ease of use at home, and convenience in exchanging data with specialists via digital platforms will continue to drive product acceptance in the home setting in the future. Furthermore, the emergence of COVID-19 has boosted demand for digital diabetes management products, such as connected devices and mobile applications used at home during the pandemic.

Geographical Analysis of Global Digital Diabetes Management Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America digital diabetes management market revenue is poised to grow significant CAGR during the forthcoming years. This can be attributed to the The presence of industry leaders, as well as an emphasis on continual technological developments and new product releases, has contributed to the regional market's growth. The region's growing patient population gives market participants with new prospects for expansion. In addition to the high prevalence of diabetes, the implementation of advantageous reimbursement rules will increase the size of the regional market. For example, in September 2020, Abbott's FreeStyle Libre 2 CGM system will be covered by Medicare for better diabetes treatment. As a result, the aforementioned factors will considerably increase demand for digital diabetes management products in North America over the forecast period.

Major Players in the Global Digital Diabetes Management Market

The key players in the digital diabetes management market

COVID-19 Impact

The COVID-19 pandemic has positively impacted the digital diabetes management market growth with increasing demand for home care technologies. With emergence of COVID-19, several countries across the globe have rapidly arranged the digital services to ensure flawless diabetes care to the patients. The COVID-19 has brought a new urgency to assess the feasibility of various digital devices in hospitals. With increasing product adoption, the companies operating in the digital diabetes management industry have experienced higher product demand during the pandemic.

Recent Developments

  • In November 2020, Ypsomed and Lilly collaborated to advance automated insulin delivery system. Under the collaboration Lilly commercialized a new version of insulin pump and CGM system that has positively impacted its business growth.
  • In September 2020, Dexcom Inc., announced the launch of G6 CGM system in Turkey. The product launch has expanded its business reach in international market.
  • In June 2020, Abbott Laboratories received the U.S. FDA approval for its CGM device, FreeStyle Libre 2. This approval helped the company in expanding their product portfolio, thereby strengthening company’s footprint in the market.
Frequently Asked QuestionsQ1. How big is the medical power supply market?Ans. The global digital diabetes management market size was USD 14.8 Million in 2021 and is anticipated to reach USD 71.9 Million in 2031, growing at a rate of 17.1% from 2022 to 2031.Q2. What is the digital diabetes management market growth rate?Ans. The growth rate of the digital diabetes management market is 17.1%.Q3. Which region holds a major market share for the market?Ans. North America holds a major market share of the digital diabetes management market in 2021.Q4. Which segment accounted for the largest digital diabetes management market share?Ans. By end user, the hospital segment accounted for the largest digital diabetes management market share.Q5. Who are the key players in the digital diabetes management market?Ans. The global digital diabetes management market report includes players such as Q6. What are the factors driving the digital diabetes management market growth?Ans. The major factors driving the growth of the market are growing diabetes populations, and advent of artificial intelligence and big data analytics in diabetes devices.Q7. What are the key growth strategies of digital diabetes management market players?Ans. The key growth strategies of digital diabetes management market players are product launch and product approval.Q8. Which region will provide more business opportunities for the digital diabetes management market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the digital diabetes management market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.


Chapter 1. Digital Diabetes Management Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Research Methodologies
1.4.1. Secondary Research
1.4.2. Market Size Estimation Technique
1.4.3. Forecasting
1.4.4. Primary Research and Data Validation
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Region
3.2. Market Attractiveness Analysis, by Product
3.3. Market Attractiveness Analysis, by Type
3.4. Market Attractiveness Analysis, by End-user
Chapter 4. Digital Diabetes Management Market Outlook
4.1. Digital Diabetes Management Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.5.1. Raw Industry Vertical Suppliers
4.5.2. Manufacturers
4.5.3. Wholesalers and/or Retailers
4.6. Impact of COVID-19 on the Flexible Endoscope Market
4.7. Impact of the Russia and Ukraine War on the Flexible Endoscope Market
Chapter 5. Digital Diabetes Management Market by Product
5.1. Market Overview
5.2. Smart Glucose Meter
5.2.1. Key Market Trends & Opportunity Analysis
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Continuous Blood Glucose Monitoring System
5.3.1. Key Market Trends & Opportunity Analysis
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.4. Smart Insulin Pens
5.4.1. Key Market Trends & Opportunity Analysis
5.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.5. Smart Insulin Pumps
5.5.1. Key Market Trends & Opportunity Analysis
5.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.6. Apps
5.6.1. Key Market Trends & Opportunity Analysis
5.6.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
Chapter 6. Digital Diabetes Management Market by Type
6.1. Market Overview
6.2. Wearable Devices
6.2.1. Market Trends & Opportunity Analysis
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Handheld Devices
6.3.1. Market Trends & Opportunity Analysis
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
Chapter 7. Digital Diabetes Management Market by End-user
7.1. Market Overview
7.2. Hospitals
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. Home Settings
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.4. Diagnostic Centers
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
Chapter 8. Flexible Endoscope Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends & Opportunity Analysis
8.2.2. North America Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.3. North America Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.2.4. North America Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.2.5. North America Digital Diabetes Management Market Size and Forecast by Country, 2021-2031, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.6.2. The U.S. Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.2.6.3. The U.S. Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.2.7. Canada
8.2.7.1. Canada Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.7.2. Canada Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.2.7.3. Canada Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.2.8.2. Mexico Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.2.8.3. Mexico Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3. Europe
8.3.1. Key Market Trends & Opportunity Analysis
8.3.2. Europe Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.3. Europe Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.4. Europe Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3.5. Europe Digital Diabetes Management Market Size and Forecast by Country, 2021-2031, ($Million)
8.3.6. Germany
8.3.6.1. Germany Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.6.2. Germany Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.6.3. Germany Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3.7. France
8.3.7.1. France Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.7.2. France Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.7.3. France Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3.8. U.K.
8.3.8.1. U.K. Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.8.2. U.K. Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.8.3. U.K. Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3.9. Spain
8.3.9.1. Spain Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.9.2. Spain Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.9.3. Spain Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3.10. Italy
8.3.10.1. Italy Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.10.2. Italy Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.10.3. Italy Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.3.11.2. Rest of Europe Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.3.11.3. Rest of Europe Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends & Opportunity Analysis
8.4.2. Asia-Pacific Digital Diabetes Management Market Size and Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.4. Asia-Pacific Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.5. Asia-Pacific Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.4.6. China
8.4.6.1. China Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.6.2. China Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.6.3. China Digital Diabetes Management Market Size and Forecast by Product Industry Vertical, 2021-2031, ($Million)
8.4.7. India
8.4.7.1. India Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.7.2. India Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.7.3. India Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.4.8. Japan
8.4.8.1. Japan Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.8.2. Japan Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.8.3. Japan Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.9.2. South Korea Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.9.3. South Korea Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.4.10. Rest of APAC
8.4.10.1. Rest of APAC Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.4.10.2. Rest of APAC Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.4.10.3. Rest of APAC Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.5. Rest of the World
8.5.1. Key Market Trends & Opportunity Analysis
8.5.2. Rest of the World Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.3. Rest of the World Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.5.4. Rest of the World Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.5.5. Rest of the World Digital Diabetes Management Market Size and Forecast by Country, 2021-2031, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.6.2. Latin America Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.5.6.3. Latin America Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.7.2. Middle East Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.5.7.3. Middle East Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
8.5.8. Africa
8.5.8.1. Africa Digital Diabetes Management Market Size and Forecast by Product, 2021-2031, ($Million)
8.5.8.2. Africa Digital Diabetes Management Market Size and Forecast by Type, 2021-2031, ($Million)
8.5.8.3. Africa Digital Diabetes Management Market Size and Forecast by End-user, 2021-2031, ($Million)
Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Vendor Benchmarking
9.4. Developmental Strategy Benchmarking
9.4.1. New Product Development
9.4.2. Product Launches
9.4.3. Business Expansions
9.4.4. Partnerships, Joint Ventures, and Collaborations
9.4.5. Mergers and Acquisitions
Chapter 10. Company Profiles
10.1. Abbott Laboratories
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Medtronic Plc
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product Offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. F.Hoffmann-La Roche Ltd
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product Offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Dexcom, Inc
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product Offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. Senseonics
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product Offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Insulet Corporation
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product Offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Tandem Diabetes Care, Inc
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product Offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Ypsomed
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product Offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Ascensia Diabetes Care Holdings Ag
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product Offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. Tidepool
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product Offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis
*The list of company is subject to change during the final compilation of the report

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings